Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 3470INDUSTRY 842NIH 454NETWORK 202OTHER_GOV 52UNKNOWN 9FED 4INDIV 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 71Genitourinary 59Thoracic 29Breast 14Lymphoid 12Other hematologic neoplasm 9Head & Neck 8Gynecologic 8Tumor-Agnostic 7Dermatologic 7CNS 4Other 3Plasma cell 2Myeloid 1Classical hematology 1

Conditions

Rare Diseases 2Neurofibromatosis 2 2Glioma 2Glioblastoma 2Genetic Diseases, Inborn 2Oligodendroglioma 1Neuroma, Acoustic 1Neurologic Manifestations 1Neurofibromatoses 1Mental Disorders 1Hearing Loss 1Brain Neoplasms 1Astrocytoma 1

Interventions

Streptozocin 1Mercaptopurine 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
FED × Interventional × CNS × Clear all
NCT07218367 2026-02-13

Phase I Trial of pH Resections of GBM at VA

VA Office of Research and Development

Phase 1 Not yet recruiting
12 enrolled
CNS

Glioblastoma, Glioma

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

FDA Office of Orphan Products Development

Phase 2 Completed
CNS

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

NCT00004688 2015-03-25

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

FDA Office of Orphan Products Development

Phase 2 Completed
35 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Genetic Diseases, Inborn, Rare Diseases

NCT00030043 2015-03-25

An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors

FDA Office of Orphan Products Development

Phase 1 Completed
10 enrolled
CNS

Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡